Clopidogrel

• Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting
  2023-504637-42-01 Phase IV 5 countries St Antonius Hospital
• Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE Recruiting
  2022-500974-33-00 Phase III 1 country Centre Hospitalier Universitaire De Saint Etienne
• Early reduction of antiplatelet therapy in patients with Acute Coronary Syndrome treated with stent implantation and at high risk of bleedin… Recruiting
  2023-509868-20-00 Phase III 1 country Azienda Ospedaliera Universitaria Gaetano Martino Messina
• Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with… Recruiting
  2024-515924-35-00 Phase IV 1 country Icahn School Of Medicine At Mount Sinai
• WOEST-3 Recruiting
  2022-502140-13-00 Phase IV 4 countries St Antonius Hospital
• Preventive effect of Clopidogrel on the systemic sclerosis development risk Recruiting
  2024-511005-39-00 Phase II/III 1 country Centre Hospitalier Universitaire De Bordeaux
• The Dan-DAPT trial Recruiting
  2022-500125-32-00 Phase IV 1 country Rigshospitalet
• Comparison between single and dual therapy with drugs that inhibits platelet aggregation in patient undergoing the percutaneous left atrial … Recruiting
  2024-515361-34-00 Phase IV 1 country Fondazione Toscana Gabriele Monasterio
• Study to evaluate reduced antiplatelet therapy after angiolite stent implantation in patients with coronary artery disease Ended
  2023-507015-35-00 Phase III 3 countries Ivascular S.L.
• A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended
  2022-501176-26-00 Phase III 22 countries Janssen - Cilag International
• The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) Ended
  2024-518547-38-00 Phase IV 1 country Rigshospitalet
• Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI (ST-ele… Ended
  2022-500383-35-00 Phase II 1 country Medical University Of Graz
• Individualized anti-platelet therapy in patients with stable coronary artery disease undergoing stenting Ended
  2023-504078-39-01 Phase IV 1 country St Antonius Hospital
• A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended
  2022-501418-69-00 Phase III 20 countries Janssen - Cilag International
• ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended
  2023-508454-26-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary … Ended
  2024-512727-36-00 Phase IV 2 countries Klinikum der Universitaet Muenchen AöR
• PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study Ended
  2024-518724-72-00 Phase IV 1 country Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• A study designed to evaluate a modified Anti-Platelet Therapy (drugs that preventblood platelets from clotting) after implantation of a Fire… Ended
  2024-519854-35-00 Phase IV 3 countries SORIN CRM SAS (Microport CRM)

Showing 25–42 of 42 trials